Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 6

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 6
---
ight           |

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 11 |

Proxy Summary

2025 Executive Compensation Overview We Pay for Performance We closely link pay and performance through the rigorous goals we set in our incentive programs and the fact that our entire long-term incentive is delivered in equity, which aligns our management team with our stockholders. CEO

AVERAGE OTHER NEOs

Elements of Compensation The following table provides additional information regarding the various elements of our 2025 executive compensation program.

|                                                                         | Pay Element                                                                                                                                                                                                                                                                                      | Objective                                                                                                                                                                                                                                              | Purpose of the Pay Element                                                                                                                                                                                      |
|                                                                         | Base Salary                                                                                                                                                                                                                                                                                      | •Skills, experience, competence,performance, responsibility, leadership andcontribution to the Company.                                                                                                                                                | •Recognize the level of job scope andcomplexity, and the skills, experience,leadership and sustained performancerequired by the executive.                                                                      |
|                                                                         | Annual CashIncentive (“AIP”)                                                                                                                                                                                                                                                                     | •Efforts to achieve annual target revenueand profitability.                                                                                                                                                                                            | •Reward the achievement of annualperformance targets.•Ensures compensation is properlyaligned to financial performance,including being completely at risk forfailure to meet annual financialthreshold targets. |
| Long-TermIncentive Awards(PerformanceStock Units,RestrictedStock Units) | •Efforts to achieve long-term revenue growthand profitability over the three yearvesting period.•Ability to increase and maintain stock price.•Achievement of adjusted cumulative EBITDAand cumulative revenue goals.•Continued employment with the Companyduring the three-year vesting period. | •Reward achievement of long-termfinancial performance and strategiccorporateinitiatives.•Provide a competitive mix ofincentives to attract and retain toptalent and to further reinforcealignment between the interests ofmanagement and stockholders. |                                                                                                                                                                                                                 |

| 12 |     | 2025 Proxy Statement | Prestige Consumer Healthcare Inc. |

Proxy Summary

Say-on-Pay Vote At the 2024 Annual Meeting of Stockholders, approximately 97% of the shares represented voted to in favor of the compensation of the Company’s named executive officers as discussed and disclosed in our 2024 Proxy Statement. In considering the results of this advisory vote on executive compensation, the Compensation and Talent Management Committee concluded that the compensation paid to our named executive officers and the Company’s overall compensation program enjoy strong stockholder support. We also regularly meet with our largest stockholders and solicit feedback on a wide range of topics, including executive compensation.